You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

ZOVIRAX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Zovirax

A generic version of ZOVIRAX was approved as acyclovir sodium by FRESENIUS KABI USA on May 13th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZOVIRAX?
  • What are the global sales for ZOVIRAX?
  • What is Average Wholesale Price for ZOVIRAX?
Summary for ZOVIRAX
Drug patent expirations by year for ZOVIRAX
Drug Prices for ZOVIRAX

See drug prices for ZOVIRAX

Recent Clinical Trials for ZOVIRAX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PT. Kimia Farma (Persero) TbkN/A
PT Pharma Metric LabsN/A
Squarex, LLCPhase 2

See all ZOVIRAX clinical trials

US Patents and Regulatory Information for ZOVIRAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norvium Bioscience ZOVIRAX acyclovir CAPSULE;ORAL 018828-001 Jan 25, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ZOVIRAX acyclovir SUSPENSION;ORAL 019909-001 Dec 22, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ZOVIRAX acyclovir sodium INJECTABLE;INJECTION 018603-003 Aug 30, 1983 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ZOVIRAX acyclovir TABLET;ORAL 020089-001 Apr 30, 1991 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ZOVIRAX acyclovir CREAM;TOPICAL 021478-001 Dec 30, 2002 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ZOVIRAX acyclovir sodium INJECTABLE;INJECTION 018603-002 Jun 29, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ZOVIRAX acyclovir OINTMENT;TOPICAL 018604-001 Mar 29, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZOVIRAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Norvium Bioscience ZOVIRAX acyclovir CAPSULE;ORAL 018828-001 Jan 25, 1985 ⤷  Sign Up ⤷  Sign Up
Bausch ZOVIRAX acyclovir OINTMENT;TOPICAL 018604-001 Mar 29, 1982 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ZOVIRAX acyclovir TABLET;ORAL 020089-001 Apr 30, 1991 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ZOVIRAX acyclovir TABLET;ORAL 020089-002 Apr 30, 1991 ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline ZOVIRAX acyclovir sodium INJECTABLE;INJECTION 018603-001 Oct 22, 1982 ⤷  Sign Up ⤷  Sign Up
Bausch ZOVIRAX acyclovir CREAM;TOPICAL 021478-001 Dec 30, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZOVIRAX

See the table below for patents covering ZOVIRAX around the world.

Country Patent Number Title Estimated Expiration
Sweden 7509675 ⤷  Sign Up
Croatia P940532 PROCESS FOR THE PREPARATION OF SUBSTITUTED PURINES ⤷  Sign Up
Norway 772959 ⤷  Sign Up
Switzerland 628897 VERFAHREN ZUR HERSTELLUNG NEUER SUBSTITUIERTER PURINE. ⤷  Sign Up
Austria A134877 ⤷  Sign Up
Spain 445980 ⤷  Sign Up
Austria A610477 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ZOVIRAX

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0809498 SPC/GB10/012 United Kingdom ⤷  Sign Up PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
0809498 10C0038 France ⤷  Sign Up PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.